Abstract
The cross‐conjugated vinylogous [4+2] anionic annulation has been newly developed, the cascade process of which has a high preference for regiochemical control and chemoselectivity, giving rise to exclusively Michael‐type adducts in moderate to high yields (up to 94 %, 35 examples). By making use of this approach as a key operation, the first total synthesis of natural antibiotic ABX, in racemic form, has been successfully achieved in a concise 7‐step sequence with an overall yield of about 20 %.
Keywords: acceptor, anionic annulation, benzylogous, donor, vinylogous
Novel vinylogous donors have been developed to carry out a unique [4+2] cascade process in a completely regio‐ and chemoselective manner, by which the first total synthesis of natural antibiotic ABX, in racemic form, was accomplished in a rather concise fashion. This versatile methodology may have great potential in synthesizing polyaromatic compounds and heterocycles.

The [4+2] anionic annulation has been widely applied to the synthesis of a variety of structurally complex molecules especially for type II polyketide natural products.1 As highlighted in red in the bioactive molecules displayed in Figure 1,2, 3, 4, 5, 6 the tandem annulation process starts with 1,4‐conjugate addition of a nucleophilic donor to an enone acceptor followed by Dieckmann–Claisen condensation to mainly generate a new six‐membered ring in a one‐pot operation, which indeed, is difficult for other synthetic methods to accomplish in such an efficient manner.
Figure 1.

Bioactive molecules synthesized through [4+2] anionic annulation.
In addition to regular Michael‐type [4+2] anionic annulation, Mannich‐ and Aldol‐type annulation are also well documented and can be viewed as the coupling of a 1,4‐dipolar and 1,2‐dipolar synthon as shown in Figure 2 a.7, 8 Some typical benzylogous donors, comprehending both phthalide and toluate donors, are selected from many historical cases and summarized in Figure 2 b.1, 9, 10 More specifically, while following the Michael‐type cascade process, Hauser–Kraus donors are featured by the formation of a para‐benzoquinone ring and others, including Staunton–Weinreb, Sammes, Swenton, and Tamura donors, are noted for the rapid construction of a cyclohexanone ring. The present work disclosed in Figure 2 c is aimed to develop hitherto unknown cross‐conjugated vinylogous donors, which are conceptually considered equivalent and/or complementary to the corresponding benzylogous counterparts, to facilitate Michael‐, Mannich‐, and Aldol‐type annulation processes, furnishing structurally diverse molecules, which are hard to be provided by any other synthetic elaborations. Practically, when making use of this newly developed methodology as a key operation, we have completed the first total synthesis of a complex natural product (±)‐ABX in a rather concise manner, details of which are presented as follows.
Figure 2.

a) General [4+2] anionic annulation. b) Benzylogous donors. c) Cross‐conjugated vinylogous donors.
ABX, also known as BE‐24566B and L755805, was first isolated in 1995 from a culture of actinomycete (MA7150) by Lam and co‐workers and was claimed to be a natural antibiotic against Gram‐positive strains including drug‐resistant bacteria VRE (vancomycin‐resistant enterococci) and MRSA (methicillin‐resistant Staphylococcus aureus).11
According to retrosynthetic analysis illustrated in Scheme 1, (±)‐ABX could be simply disconnected into two major fragments 1 and 2 through pathway A or fragments 3 and 4 through pathway B. Fragments 1 and 3 are anticipated to serve as novel vinylogous donors to execute similar Michael‐type annulation to traditional benzylogous donors because they all possess an acidic γ proton which should be deprotonated by an appropriate base to form the corresponding nucleophilic dienolates as illustrated in Figure 2 c. Approach A was preferentially taken owing to our previously substantial experience in preparation of a variety of cross‐conjugated dienophiles for the Diels–Alder reaction.12 The current work began with synthesizing enone ester 5, bearing a high structural similarity to 1, as a model compound for the proof‐of‐concept (Scheme 2). Commercially available tetralone 6 was first treated with dimethyl carbonate in the presence of sodium hydride to form the corresponding β‐keto ester which, without purification, was oxidized with DDQ to afford enone ester 7 in 89 % yield over two steps.
Scheme 1.

Retrosynthetic analysis of (±)‐ABX.
Scheme 2.

Preparation of cross‐conjugated vinylogous donor 5.
Compound 7 was then subjected to 1,4‐conjugate addition with MeMgBr under catalysis with CuI to afford β‐methyl keto ester (98 %), which sequentially underwent bromination and 1,2‐elimination to accomplish the desired target 5 in 74 % yield over two repeated cycles. Compound 5, a potential vinylogous donor, and methyl acrylate, a typical Michael acceptor, were then used to test the proposed Michael‐type [4+2] anionic annulation.
Various combinations of reaction parameters, such as solvents, bases, and temperature elevation, were explored to screen the optimal reaction conditions. Results are compiled in Table 1 and discussed thereby. As indicated in entries 1–5, originally, we thought the γ proton should be quite acidic, and thus weak bases, such as Li2CO3, Na2CO3, K2CO3, DBU, and Cs2CO3, were attempted. As a result, the expected product 8 (entry 2) was merely obtained in 18 % yield while Na2CO3 was used at elevated temperature (150 °C) in DMF, suggesting that stronger bases might be required to drive the reaction forward. As such, LiHMDS, NaHMDS, KHMDS, and NaH (entries 6–11) were tried. To our delight, reactions could be significantly improved, giving rise to the desired product 8 in 24–75 % yields at much lower temperature (66–110 °C). Reaction conditions shown in entries 6 (63 %) and 10 (75 %) seem to be promising and deserve to be further modified. In one approach, when the amount of base (LiHMDS) and Michael acceptor in entry 10 was reduced to 1.1 equiv, the reaction system in entry 11 (83 % yield) was tentatively considered optimum and adopted as a standard protocol for the newly developed Michael‐type annulation process. Medium‐strong bases, including tBuOLi, tBuONa, and tBuOK, were also tested based on the standard conditions, results of which again suggested that the base with the lithium counter cation could afford product 8 in the highest yield (entry 12; 79 %, tBuOLi). These results along with a wealth of well‐documented literature strongly support that lithium bases appear superior to others presumably due to their multifunction Li+ cation, allowing it to be effectively chelated with both dienolate ion and α‐ester carbonyl after enolization (Figure 2 c) and activate oxygen‐containing electrophiles through its strong oxophilicity, thereby not only initiating 1,4‐conjugate addition but also facilitating the subsequent ring closure.1b, 13 To examine the generality of this newly developed method, many structurally diverse vinylogous donors and Michael acceptors were randomly paired off and desired products were commonly achieved in moderate to high yields (36–94 %) as listed in Table 2. To make Michael‐type adducts more readable, those parts of products highlighted in blue are derived from vinylogous donors, which contain the 1‐tetralone, verbenone, coumarin, chromone, 2‐quinolone, γ‐lactam, or γ‐lactone moiety, and those in green are from Michael acceptors, containing a α,β‐unsaturated ketone, lactone, aldehyde, ester, phosnate, sulfone, or nitrile unit. We observed that some vinylogous donors are much more reactive than the model donor 5, and the annulation process can be affected at lower temperature (0–50 °C) and shorter reaction time to obtain the corresponding non‐aromatized intermediates instead. In those cases, further dehydrogenation with a stronger oxidant DDQ rather than mild dry air (O2) was required to reach the final aromatized products as exemplified with adducts 15–17, 23, and 34. Some Michael acceptors highlighted in green in adducts 11, 18, 26, 27, 32, 38, and 42 are quinone monoketals, which have been known to possess redox activity,14 and could play dual functions to provide both desired and redox products. Taking acceptor 43 as an example (Scheme 3 a), when it was coupled with donor 5 under standard conditions, the regular product 11 was formed in 51 % yield accompanied with a redox product 44 in 44 % yield. After careful examination, similar redox property was also found in α,β‐unsaturated tetralone acceptors that we used to generate adducts 24, 25, and 33. As evidenced by a typical example (Scheme 3 b), product 33 and a reduced byproduct 47 were isolated in 48 % and 42 % yield, respectively, under standard conditions. However, when charged with 2.1 equiv of acceptor 46, the reaction reached completion and the desirable product 33 was obtained in 71 % yield.
Table 1.
Screening of vinylogous [4+2] annulation conditions.
|
Entry |
Michael acceptor |
Base (equiv) |
Solvent |
T [°C]/t [h] |
Isolated yield |
|---|---|---|---|---|---|
|
1. |
(1.5 equiv) |
Li2CO3 (1.5 equiv) |
DMF |
150 °C/15 h |
trace[b] |
|
2. |
(1.5 equiv) |
Na2CO3 (1.5 equiv) |
DMF |
150 °C/15 h |
18 %[b] |
|
3. |
(1.5 equiv) |
K2CO3 (1.5 equiv) |
DMF |
150 °C/2 h |
trace |
|
4. |
(1.5 equiv) |
Cs2CO3 (1.5 equiv) |
DMF |
150 °C/2 h |
0 % |
|
5. |
(1.5 equiv) |
DBU (1.5 equiv) |
toluene |
110 °C/6 h |
0 %[c] |
|
6. |
(1.5 equiv) |
LiHMDS (1.5 equiv) |
THF |
66 °C/15 h |
63 %[b] |
|
7. |
(1.5 equiv) |
NaHMDS (1.5 equiv) |
THF |
66 °C/2 h |
44 % |
|
8. |
(1.5 equiv) |
KHMDS (1.5 equiv) |
THF |
0–66 °C/2 h |
25 % |
|
9. |
(1.5 equiv) |
NaH (2.0 equiv) |
THF |
66 °C/15 h |
24 % |
|
10. |
(1.5 equiv) |
LiHMDS (1.5 equiv) |
toluene |
110 °C/15 h |
75 % |
|
11. |
(1.1 equiv) |
LiHMDS (1.1 equiv) |
toluene |
110 °C/15 h |
83 % |
|
12. |
(1.1 equiv) |
tBuOLi (1.1 equuiv.) |
toluene |
110 °C/6 h |
79 % |
|
13. |
(1.1 equiv) |
tBuONa (1.1 equiv) |
toluene |
110 °C/6 h |
61 % |
|
14. |
(1.1 equiv) |
tBuOK (1.1 equiv) |
toluene |
110 °C/6 h |
trace |
[a] All reactions were performed in solvent (0.2 m) as indicated above under dry air. [b] Donor 5 and its dienol tautomer 5 a were not completely consumed and recovered. [c] Only donor 5 was recovered.
Table 2.
Scope of Michael‐type [4+2] anionic annulation.
|
|
[a] Condition A: All reactions were performed in toluene (0.2 m) under dry air. [b] Condition B: Instead of air, DDQ was used as an oxidant. [c] Condition C: 2.1 equiv of the Michael acceptor was used. [d] A linear acetylenic Michael acceptor was used. [e] THF was used instead to increase the poor solubility of the donor of compound 18.
Scheme 3.

Some Michael acceptors also play a role as an oxidant in [4+2] annulation.
To provide the mechanistic insight into the cascade annulation, a typical reaction under condition A was then carried out but quenched at 0 °C before heating. Consequently, donor 5 and its dienol tautomer 5 a (1:9), as determined by 1H NMR of the crude mixture,15 was completely recovered, suggesting that deprotonation did occur but the Michael–Dieckmann sequence was not activated. Additionally, no 1,4‐conjugate addition intermediates had been identified for many other vinylogous donors that we used to generate adducts 15–17, 23–26, 32, and 34 (Table 2), wherein all reactions were conducted and completed at lower temperature (0–50 °C). Taken together, these results imply that Michael addition is very likely to be a rate‐limiting step in the above domino reactions; once it is initiated, the ensuing Dieckmann condensation might take place spontaneously. Structurally, though vinylogous donors potentially suffer self‐condensation through their cross‐conjugated dienolates after deprotonation,1c, 16 however, no self‐condensation products have been detected in all cases (35 examples) examined under reaction condition A, B, and C in Table 2. According to retrosynthetic analysis shown in pathway A (Scheme 1), fragments 1 and 2 are apparently two feasible chemical elements to implement the Michael‐type [4+2] anionic annulation which had been experimentally realized in many cases as shown in Table 2. Encouraged by these results, we decided to carry out the total synthesis of (±)‐ABX based on the original design (Scheme 4). Starting with bis‐benzyl protected tetralone 48, enone ester 50 was readily prepared in 57 % over 4 steps through a similar synthetic sequence for enone ester 5 as depicted in Scheme 2. Vinylogous donor 50 was then treated with aldehyde 2 under standard conditions to afford tricyclic aldehyde 53 in 53 % yield. Aldehyde 2 was readily prepared in 78 % yield through a Wittig reaction in the presence of ylide 51 and 2‐butynal, formed in situ by oxidation of 2‐butynol with MnO2. A series of cascade events, involving metal‐catalyzed cycloisomerization, proton demetallation, Friedel–Crafts acylation, and ring closure, was then successfully triggered between compound 53 and orcinol under catalysis with PtCl2 to give the corresponding intermediates 55 and 56 (1:1 as determined by 1H NMR), which contained requisite D, E, and F rings by putatively invoking the intermediacy of the metal‐benzopyrilium 54 species as an initiator.17 Without purification, the mixture was further deprotected through hydrogenolysis under catalysis with Pd/C to accomplish the desired target, in racemic form, in 65 % yield over 2 steps. The 1H NMR, 13C NMR, and mass spectral data obtained for the synthetic (±)‐ABX, whose structure is further unambiguously confirmed by an X‐ray crystallographic analysis,18 are in good agreement with those reported for the naturally occurring product.11c, 11d, 19
Scheme 4.

Application to the total synthesis of (±)‐ABX.
Vinylogous [4+2] anionic annulation can also be applied to other 1,2‐dipolar synthons such as the cyano or imine group to rapidly incorporate a pyridine‐2‐ol or pyridine‐2‐one unit in various alkaloid systems, historically, many of which might potentially possess a wide range of biological activities.20 As listed in Table 3, all cases examined turned out to be fruitless (0 % yield) when vinylogous donors were individually treated with 1,2‐dipolar acceptors under standard reaction conditions. However, as an extra ZnI2 (0.2 equiv) was added, the desired [4+2] annulation was activated, providing products 57–62 in moderate to good yields (51–86 %). As for the aldol‐type annulation, though the corresponding lactones (for eample, 63) were allowed to form under standard conditions, they are quite labile and prone to undergo lactone‐ring cleavage to give thermodynamically more stable conjugated products, particularly when aryl aldehydes were used as acceptors as seen in acid products 64 (77 %) and 65 (84 %). Similar ring‐opening results had also been observed and reported by J. M. Charlton, et al.21 Collectively, it could be declared that the methodology described above is eligible to proceed in a regio‐ and chemocontrol manner, and should have great synthetic utility in terms of its operational simplicity and easy access to a variety of cross‐conjugated vinylogous donors.
Table 3.
Scope of Mannich‐ and Aldol‐type [4+2] anionic annulation.
|
|
[a] The same as condition A in Table 2. [b] Lewis acid ZnI2 (0.2 equiv) was added. [c] 1, 3, 5‐triazine was used as an acceptor. [d] THF was used as solvent to increase the poor solubility of all imine acceptors.
In conclusion, the first total synthesis of (±)‐ABX has been successfully achieved by making use of a vinylogous Michael‐type annulation approach that is rather efficient in light of regiochemical control, a short synthetic sequence involved (7 steps), and the overall yield (about 20 %). In association with well‐documented benzylogous donors, the newly developed protocol with particular emphasis on creating vinylogous donors may augment synthetic capacity greatly to expand the structural diversity of a molecular library for screening various natural and/or non‐natural antibiotics, especially possessing a pharmacophore featured with an aromatic polyketide‐type scaffold, in both pharmaceutical and academic frontiers.
Conflict of interest
The authors declare no conflict of interest.
Supporting information
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Supplementary
Acknowledgements
We are grateful to the Ministry of Science and Technology (MOST 106‐2113‐M‐400‐004‐MY2; MOST 108‐2113‐M‐400‐005) and National Health Research Institutes of the Republic of China for financial support.
J.-K. Huang, K.-S. Shia, Angew. Chem. Int. Ed. 2020, 59, 6540.
Dedicated to Professor Hsing‐Jang Liu on the occasion of his 75th birthday
References
- 1.Books:
- 1a. Mal D., Anionic Annulations in Organic Synthesis, Elsevier, Amsterdam, 2019; [Google Scholar]
- 1b. Clark R. D., Jahangir A., Org. React. 1995, 47, 1–314; Reviews: [Google Scholar]
- 1c. Donner C. D., Tetrahedron 2013, 69, 3747–3773; [Google Scholar]
- 1d. Rathwell K., Brimble M. A., Synthesis 2007, 643–662; [Google Scholar]
- 1e. Mal D., Pahari P., Chem. Rev. 2007, 107, 1892–1918; [DOI] [PubMed] [Google Scholar]
- 1f. Mitchell A. S., Russell R. A., Tetrahedron 1995, 51, 5207–5236. [Google Scholar]
- 2.
- 2a. Nicolaou K. C., Liu G., Beabout K., McCurry M. D., Shamoo Y., J. Am. Chem. Soc. 2017, 139, 3736–3746; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2b. Nicolaou K. C., Hale C. R., Nilewski C., Ioannidou H. A., ElMarrouni A., Nilewski L. G., Beabout K., Wang T. T., Shamoo Y., J. Am. Chem. Soc. 2014, 136, 12137–12160; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2c. Nicolaou K. C., Nilewski C., Hale C. R. H., Ioannidou H. A., ElMarrouni A., Koch L. G., Angew. Chem. Int. Ed. 2013, 52, 8736–8741; [DOI] [PMC free article] [PubMed] [Google Scholar]; Angew. Chem. 2013, 125, 8898–8904. [Google Scholar]
- 3.
- 3a. Myers A. G., Tom N. J., Fraley M. E., Cohen S. B., Madar D. J., J. Am. Chem. Soc. 1997, 119, 6072–6094; [Google Scholar]
- 3b. Shair M. D., Yoon T. Y., Mosny K. K., Chou T. C., Danishefsky S. J., J. Am. Chem. Soc. 1996, 118, 9509–9525; [Google Scholar]
- 3c. Myers A. G., Fraley M. E., Tom N. J., Cohen S. B., Madar D. J., Chem. Biol. 1995, 2, 33–43; [DOI] [PubMed] [Google Scholar]
- 3d. Shair M. D., Yoon T. Y., Danishefsky S. J., Angew. Chem. Int. Ed. Engl. 1995, 34, 1721–1723; [Google Scholar]; Angew. Chem. 1995, 107, 1883–1885; [Google Scholar]
- 3e. Myers A. G., Fraley M. E., Tom N. J., J. Am. Chem. Soc. 1994, 116, 11556–11557. [Google Scholar]
- 4.
- 4a. Kita Y., Higuchi K., Yoshida Y., Iio K., Kitagaki S., Ueda K., Akai S., Fujioka H., J. Am. Chem. Soc. 2001, 123, 3214–3222; [DOI] [PubMed] [Google Scholar]
- 4b. Kita Y., Higuchi K., Yoshida Y., Iio K., Kitagaki S., Akai S., Fujioka H., Angew. Chem. Int. Ed. 1999, 38, 683–686; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 1999, 111, 731–734; [Google Scholar]
- 4c. Boger D. L., Huter O., Mbiya K., Zhang M. S., J. Am. Chem. Soc. 1995, 117, 11839–11849; [Google Scholar]
- 4d. Clive D. L. J., Tao Y., Khodabocus A., Wu Y. J., Angoh A. G., Bennett S. M., Boddy C. N., Bordeleau L., Kellner D., Kleiner G., Middleton D. S., Nichols C. J., Richardson S. R., Vernon P. G., J. Am. Chem. Soc. 1994, 116, 11275–11286; [Google Scholar]
- 4e. Boger D. L., Jacobson I. C., J. Org. Chem. 1991, 56, 2115–2122. [Google Scholar]
- 5.
- 5a. Huang J.-K., Yang Lauderdale T.-L., Lin C.-C., Shia K.-S., J. Org. Chem. 2018, 83, 6508–6523; [DOI] [PubMed] [Google Scholar]
- 5b. Wang S., Kraus G. A., J. Org. Chem. 2018, 83, 15549–15552. [DOI] [PubMed] [Google Scholar]
- 6.
- 6a. Ronn M., Zhu Z. J., Hogan P. C., Zhang W. Y., Niu J., Katz C. E., Dunwoody N., Gilicky O., Deng Y. H., Hunt D. K., He M. S., Chen C. L., Sun C. X., Clark R. B., Xiao X. Y., Org. Process Res. Dev. 2013, 17, 838–845; [Google Scholar]
- 6b. Sun C. X., Wang Q., Brubaker J. D., Wright P. M., Lerner C. D., Noson K., Charest M., Siegel D. R., Wang Y. M., Myers A. G., J. Am. Chem. Soc. 2008, 130, 17913–17927; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6c. Charest M. G., Lerner C. D., Brubaker J. D., Siege D. R., Myers A. G., Science 2005, 308, 395–398. [DOI] [PubMed] [Google Scholar]
- 7.Mannich-type articles:
- 7a. Jarvis C. L., Hirschi J. S., Vetticatt M. J., Seidel D., Angew. Chem. Int. Ed. 2017, 56, 2670–2674; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2017, 129, 2714–2718; [Google Scholar]
- 7b. Cronin S. A., Gutiérrez Collar A., Gundala S., Cornaggia C., Torrente E., Manoni F., Botte A., Twamley B., Connon S. J., Org. Biomol. Chem. 2016, 14, 6955–6959; [DOI] [PubMed] [Google Scholar]
- 7c. Hahn R., Jafari E., Raabe G., Enders D., Synthesis 2015, 47, 472–480; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7d. Wada A., Hirai S., Hanaoka M., Chem. Pharm. Bull. 1991, 39, 1189–1192; [Google Scholar]
- 7e. Cushman M., Gentry J., Dekow F. W., J. Org. Chem. 1977, 42, 1111–1116; [DOI] [PubMed] [Google Scholar]
- 7f. Haimova M. A., Mollov N. M., Ivanova S. C., Dimitrova A. I., Ognyanov V. I., Tetrahedron 1977, 33, 331–336. [Google Scholar]
- 8.Aldol-type articles:
- 8a. Wang H., Chen X., Li Y., Wang J., Wu S., Xue W., Yang S., Chi Y. R., Org. Lett. 2018, 20, 333–336; [DOI] [PubMed] [Google Scholar]
- 8b. Aiello M. L., Farid U., Trujillo C., Twamley B., Connon S. J., J. Org. Chem. 2018, 83, 15499–15511. [DOI] [PubMed] [Google Scholar]
- 9.
- 9a. Mal D., Ghosh K., Chakraborty S., Synthesis 2015, 47, 2473–2484; [Google Scholar]
- 9b. Warrener R. N., Liu L. G., Russell R. A., Tiekink E. R. T., Synlett 1998, 4, 387–388; [Google Scholar]
- 9c. Katritzky A. R., Zhang G., Xie L., Synth. Commun. 1997, 27, 3951–3961; [Google Scholar]
- 9d. Majumdar G., Pal R., Murty K. V. S. N., Mal D., J. Chem. Soc. Perkin Trans. 1 1994, 309–316; [Google Scholar]
- 9e. Watanabe M., Morimoto H., Nogami K., Ijichi S., Furukawa S., Chem. Pharm. Bull. 1993, 41, 968–970; [Google Scholar]
- 9f. Tamura Y., Sasho M., Nakagawa K., Tsugoshi T., Kita Y., J. Org. Chem. 1984, 49, 473–478; [Google Scholar]
- 9g. Chenard B. L., Anderson D. K., Swenton J. S., J. Chem. Soc. Chem. Commun. 1980, 932–933; [Google Scholar]
- 9h. Evans G. E., Leeper F. J., Murphy J. A., Staunton J., J. Chem. Soc. Chem. Commun. 1979, 205–206; [Google Scholar]
- 9i. Leeper F. J., Staunton J., J. Chem. Soc. Chem. Commun. 1979, 206–207; [Google Scholar]
- 9j. Dodd J. H., Weinreb S. M., Tetrahedron Lett. 1979, 20, 3593–3596; [Google Scholar]
- 9k. Hauser F. M., Rhee R. P., J. Org. Chem. 1978, 43, 178–180; [Google Scholar]
- 9l. Kraus G. A., Sugimoto H., Tetrahedron Lett. 1978, 19, 2263–2266; [Google Scholar]
- 9m. Broom N. J. P., Sammes P. G., J. Chem. Soc. Chem. Commun. 1978, 162–164; [Google Scholar]
- 9n. Wildeman J., Borgen P. C., Pluim H., Rouwette P. H. F. M., van Leusen A. M., Tetrahedron Lett. 1978, 19, 2213–2216; [Google Scholar]
- 9o. Kraus G. A., Sugimoto H., Synth. Commun. 1977, 7, 505–508. [Google Scholar]
- 10.For selected articles using benzylogous [4+2] anionic annulation as a key step to synthesize various natural products, see:
- 10a. Holmbo S. D., Pronin S. V., J. Am. Chem. Soc. 2018, 140, 5065–5068; [DOI] [PubMed] [Google Scholar]
- 10b. Mal D., Jana S., J. Org. Chem. 2016, 81, 11857–11865; [DOI] [PubMed] [Google Scholar]
- 10c. Odagi M., Furukori K., Yamamoto Y., Sato M., Iida K., Yamanaka M., Nagasawa K., J. Am. Chem. Soc. 2015, 137, 1909–1915; [DOI] [PubMed] [Google Scholar]
- 10d. Huang J.-K., Yang Lauderdale T.-L., Shia K.-S., Org. Lett. 2015, 17, 4248–4251; [DOI] [PubMed] [Google Scholar]
- 10e. Adachi S., Watanabe K., Iwata Y., Kameda S., Miyaoka Y., Onozuka M., Mitsui R., Saikawa Y., Nakata M., Angew. Chem. Int. Ed. 2013, 52, 2087–2091; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2013, 125, 2141–2145; [Google Scholar]
- 10f. Magauer T., Smaltz D. J., Myers A. G., Nat. Chem. 2013, 5, 886–893; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10g. Tatsuta K., Fukuda T., Ishimori T., Yachi R., Yoshida S., Hashimoto H., Hosokawa S., Tetrahedron Lett. 2012, 53, 422–425; [Google Scholar]
- 10h. Liau B. B., Milgram B. C., Shair M. D., J. Am. Chem. Soc. 2012, 134, 16765–16772; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10i. Matsumoto T., Yamaguchi H., Tanabe M., Yasui Y., Suzuki K., Tetrahedron Lett. 2000, 41, 8393–8396; [Google Scholar]
- 10j. Kuniaki T., Takuji Y., Hiroki G., Yoshiya O., Masaaki T., Chem. Lett. 2000, 29, 646–647. [Google Scholar]
- 11.
- 11a. Herath K. B., Jayasuriya H., Guan Z. Q., Schulman M., Ruby C., Sharma N., MacNaul K., Menke J. G., Kodali S., Galgoci A., Wang J., Singh S. B., J. Nat. Prod. 2005, 68, 1437–1440; [DOI] [PubMed] [Google Scholar]
- 11b. Kodali S., Galgoci A., Young K., Painter R., Silver L. L., Herath K. B., Singh S. B., Cully D., Barrett J. F., Schmatz D., Wang J., J. Biol. Chem. 2005, 280, 1669–1677; [DOI] [PubMed] [Google Scholar]
- 11c. Kojiri K., Nakajima S., Fuse A., Suzuki H., Suda H., J. Antibiot. 1995, 48, 1506–1508; [DOI] [PubMed] [Google Scholar]
- 11d. Lam Y. K. T., Hensens O., Helms G., Williams D., Nallin M., Smith J., Gartner S., Rodriguez L. H., Stevensmiles S., Tetrahedron Lett. 1995, 36, 2013–2016. [Google Scholar]
- 12. Wu Y.-K., Ly T. W., Shia K.-S., Curr. Org. Chem. 2010, 7, 78–93. [Google Scholar]
- 13.
- 13a. Patel J. J., Laars M., Gan W., Board J., Kitching M. O., Snieckus V., Angew. Chem. Int. Ed. 2018, 57, 9425–9429; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2018, 130, 9569–9573; [Google Scholar]
- 13b. Huang K.-H., Huang C.-C., Isobe M., J. Org. Chem. 2016, 81, 1571–1584; [DOI] [PubMed] [Google Scholar]
- 13c. Lu H.-H., Martinez M. D., Shenvi R. A., Nat. Chem. 2015, 7, 604–607; [DOI] [PubMed] [Google Scholar]
- 13d. Peng Z., Ragan J. A., Colon-Cruz R., Conway B. G., Cordi E. M., Leeman K., Letendre L. J., Ping L.-J., Sieser J. E., Singer R. A., Sluggett G. W., Strohmeyer H., Vanderplas B. C., Blunt J., Mawby N., Meldrum K., Taylor S., Org. Process Res. Dev. 2014, 18, 36–44; [Google Scholar]
- 13e. Shen X., Zhang L., Zhao Y., Zhu L., Li G., Hu J., Angew. Chem. Int. Ed. 2011, 50, 2588–2592; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2011, 123, 2636–2640; [Google Scholar]
- 13f. Hasaninejad A., Zare A., Mohammadizadeh M. R., Shekouhy M., Green Chem. Lett. Rev. 2010, 3, 143–148; [Google Scholar]
- 13g. Ischay M. A., Anzovino M. E., Du J., Yoon T. P., J. Am. Chem. Soc. 2008, 130, 12886–12887; [DOI] [PubMed] [Google Scholar]
- 13h. Hatano M., Ikeno T., Matsumura T., Torii S., Ishihara K., Adv. Synth. Catal. 2008, 350, 1776–1780; [Google Scholar]
- 13i. Snieckus V., Chem. Rev. 1990, 90, 879–933. [Google Scholar]
- 14.
- 14a. Sharma S., Parumala S. K. R., Peddinti R. K., J. Org. Chem. 2017, 82, 9367–9383; [DOI] [PubMed] [Google Scholar]
- 14b. Villaume M. T., Sella E., Saul G., Borzilleri R. M., Fargnoli J., Johnston K. A., Zhang H., Fereshteh M. P., Dhar T. G. M., Baran P. S., ACS Cent. Sci. 2016, 2, 27–31; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14c. Hsu C.-S., Chou H.-H., Fang J.-M., Org. Biomol. Chem. 2015, 13, 5510–5519; [DOI] [PubMed] [Google Scholar]
- 14d. Song L., Zhu G., Liu Y., Liu B., Qin S., J. Am. Chem. Soc. 2015, 137, 13706–13714; [DOI] [PubMed] [Google Scholar]
- 14e. Swenton J. S., Acc. Chem. Res. 1983, 16, 74–81. [Google Scholar]
- 15.After a usual work-up, the crude residue was dissolved in CDCl3 and measured with 1H and 13C NMR. The ratio of 5 and 5 a was found to change dynamically from 1:9 at an initial time point to 2:3 in 24 h, and 3:1 in 48 h. Please see spectral analyses on S16, S49, S50, and S51 in the Supporting Information.
- 16.
- 16a. Tan N. P. H., Donner C. D., Tetrahedron Lett. 2008, 49, 4160–4162; [Google Scholar]
- 16b. Carpenter T. A., Evans G. E., Leeper F. J., Staunton J., Wilkinson M. R., J. Chem. Soc. Perkin Trans. 1 1984, 1043–1051; [Google Scholar]
- 16c. Hauser F. M., Rhee R. P., Prasanna S., Weinreb S. M., Dodd J. H., Synthesis 1980, 72–74. [Google Scholar]
- 17.
- 17a. Oh C. H., Yi H. J., Lee J. H., Lim D. H., Chem. Commun. 2010, 46, 3007–3009; [DOI] [PubMed] [Google Scholar]
- 17b. Hsu Y.-C., Ting C.-M., Liu R.-S., J. Am. Chem. Soc. 2009, 131, 2090–2091; [DOI] [PubMed] [Google Scholar]
- 17c. Beeler A. B., Su S., Singleton C. A., Porco J. A., J. Am. Chem. Soc. 2007, 129, 1413–1419; [DOI] [PubMed] [Google Scholar]
- 17d. Asao N., Aikawa H., Yamamoto Y., J. Am. Chem. Soc. 2004, 126, 7458–7459; [DOI] [PubMed] [Google Scholar]
- 17e. Asao N., Nogami T., Lee S., Yamamoto Y., J. Am. Chem. Soc. 2003, 125, 10921–10925; [DOI] [PubMed] [Google Scholar]
- 17f. Asao N., Takahashi K., Lee S., Kasahara T., Yamamoto Y., J. Am. Chem. Soc. 2002, 124, 12650–12651. [DOI] [PubMed] [Google Scholar]
- 18.CCDC https://www.ccdc.cam.ac.uk/services/structures?id=doi:10.1002/anie.201914657 (synthetic (±)-ABX) contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from http://www.ccdc.cam.ac.uk/.
- 19.
- 19a. Mei X. Y., Yan X. L., Zhang H., Yu M. J., Shen G. Q., Zhou L. J., Deng Z. X., Lei C., Qu X. D., ACS Chem. Biol. 2018, 13, 200–206; [DOI] [PubMed] [Google Scholar]
- 19b. Chen H. Y., Liu N., Huang Y., Chen Y. H., Tetrahedron: Asymmetry 2014, 25, 113–116. [Google Scholar]
- 20.
- 20a. Torres M., Gil S., Parra M., Curr. Org. Chem. 2005, 9, 1757–1779; [Google Scholar]
- 20b. Kobayashi J., Hirasawa Y., Yoshida N., Morita H., J. Org. Chem. 2001, 66, 5901–5904; [DOI] [PubMed] [Google Scholar]
- 20c. Liu J.-S., Zhu Y.-L., Yu C.-M., Zhou Y.-Z., Han Y.-Y., Wu F.-W., Qi B.-F., Can. J. Chem. 1986, 64, 837–839; [Google Scholar]
- 20d. Misra R., Pandey R. C., Silverton J. V., J. Am. Chem. Soc. 1982, 104, 4478–4479; [Google Scholar]
- 20e. Wall M. E., Wani M. C., Cook C. E., Palmer K. H., McPhail A. T., Sim G. A., J. Am. Chem. Soc. 1966, 88, 3888–3890. [Google Scholar]
- 21. Charlton J. M., Sayeed V. A., Lypka G. N., Can. J. Chem. 1982, 60, 1996–2001. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Supplementary
